Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2008 (Vol. 28, No. 6)

Biotechnology, Pharmaceutical, and Life Science Classifieds and Directory

URL:www.biolistings.com
  • News, classifieds
  • Very unfocused
Another month, another site dedicated to putting researchers together. This one takes a sort of multi-tiered approach that is a bit unusual. Looking like a sort of combination of a classified ads site and a news site, Biolistings looks like it is still getting its feet on the ground. The message I had from the CEO indicated that the original intent was to “to create a free, CraigsList-type application that would enable small companies and researchers to find or advertise used equipment to each other.” Mercifully, they abandoned that notion, but what the site has morphed into is hard to encapsulate. It includes a good section of news, as well as companies trying to sell you things. It includes a Life Sciences directory that only contains 27 entries under the category of Biotech Companies, but 38 under Architects! There appears to be a bit of a focus problem. Registration is required for full access, so there may be more to this site than what meets the eye of a freeloader like me, but I’m not so sure. Worth a look, but probably not worth a lot of your time.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »